[
    [
        {
            "time": "",
            "original_text": "白雲山(00874)化學新藥注射用頭孢嗪脒鈉於近期正式啟動臨床I期試驗",
            "features": {
                "keywords": [
                    "白雲山",
                    "頭孢嗪脒鈉",
                    "臨床I期試驗",
                    "化學新藥"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山(00874)化學新藥注射用頭孢嗪脒鈉於近期正式啟動臨床I期試驗",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "白雲山(00874.HK)：注射用頭孢嗪脒鈉近期啟動臨床I期試驗",
            "features": {
                "keywords": [
                    "白雲山",
                    "頭孢嗪脒鈉",
                    "臨床I期試驗"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山(00874.HK)：注射用頭孢嗪脒鈉近期啟動臨床I期試驗",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "白雲山現1筆大宗交易 共成交201.46萬元",
            "features": {
                "keywords": [
                    "白雲山",
                    "大宗交易",
                    "201.46萬元"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白雲山現1筆大宗交易 共成交201.46萬元",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]